132 related articles for article (PubMed ID: 18061272)
1. Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone.
Nurchi VM; Crisponi G; Pivetta T; Donatoni M; Remelli M
J Inorg Biochem; 2008 Apr; 102(4):684-92. PubMed ID: 18061272
[TBL] [Abstract][Full Text] [Related]
2. Molecular factors affecting the complex formation between deferiprone (L1) and Cu(II). Possible implications on efficacy and toxicity.
Pashalidis I; Kontoghiorghes GJ
Arzneimittelforschung; 2001; 51(12):998-1003. PubMed ID: 11799848
[TBL] [Abstract][Full Text] [Related]
3. Towards a new attenuating compound: a potentiometric, spectrophotometric and NMR equilibrium study on Fe(III), Al(III) and a new tetradentate mixed bisphosphonate-hydroxypyridinonate ligand.
Crisponi G; Nurchi VM; Pivetta T; Gałezowska J; Gumienna-Kontecka E; Bailly T; Burgada R; Kozłowski H
J Inorg Biochem; 2008 Jul; 102(7):1486-94. PubMed ID: 18299150
[TBL] [Abstract][Full Text] [Related]
4. Copper complexation by 3-hydroxypyridin-4-one iron chelators: structural and iron competition studies.
el-Jammal A; Howell PL; Turner MA; Li N; Templeton DM
J Med Chem; 1994 Feb; 37(4):461-6. PubMed ID: 7509878
[TBL] [Abstract][Full Text] [Related]
5. Complexation of iron with the orally active decorporation drug L1 (3-hydroxy-1,2-dimethyl-4-pyridinone).
Kline MA; Orvig C
Clin Chem; 1992 Apr; 38(4):562-5. PubMed ID: 1568323
[TBL] [Abstract][Full Text] [Related]
6. Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.
Sheppard LN; Kontoghiorghes GJ
Arzneimittelforschung; 1993 Jun; 43(6):659-63. PubMed ID: 8352819
[TBL] [Abstract][Full Text] [Related]
7. Iron chelation properties of an extracellular siderophore exochelin MN.
Dhungana S; Miller MJ; Dong L; Ratledge C; Crumbliss AL
J Am Chem Soc; 2003 Jun; 125(25):7654-63. PubMed ID: 12812507
[TBL] [Abstract][Full Text] [Related]
8. Interactions of hydroxycarbamide (hydroxyurea) with iron and copper: implications on toxicity and therapeutic strategies.
Konstantinou E; Pashalidis I; Kolnagou A; Kontoghiorghes GJ
Hemoglobin; 2011; 35(3):237-46. PubMed ID: 21599436
[TBL] [Abstract][Full Text] [Related]
9. Iron complexes of new pentadentate ligands containing the 1,4,7-triazacyclononane-1,4-diacetate motif. spectroscopic, electro-, and photochemical studies.
Song YF; Berry JF; Bill E; Bothe E; Weyhermüller T; Wieghardt K
Inorg Chem; 2007 Mar; 46(6):2208-19. PubMed ID: 17315865
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67Ga.
Santos MA; Gil M; Gano L; Chaves S
J Biol Inorg Chem; 2005 Aug; 10(5):564-80. PubMed ID: 16133203
[TBL] [Abstract][Full Text] [Related]
11. Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1H)-pyridones - Attempted optimization of the orally active iron chelator, deferiprone.
Xie YY; Lu Z; Kong XL; Zhou T; Bansal S; Hider R
Eur J Med Chem; 2016 Jun; 115():132-40. PubMed ID: 27014847
[TBL] [Abstract][Full Text] [Related]
12. Use of electrochemical transient techniques to obtain thermodynamic and kinetic data on aqueous Fe(III)-1,6-dimethyl-4-hydroxy-3-pyridinecarboxylate and Fe(III)-4-hydroxy-2-methyl-3-pyridinecarboxylate complexes.
Badocco D; Marcon M; Mondin A; Dean A; Di Marco VB; Pastore P
Dalton Trans; 2009 Apr; (13):2415-22. PubMed ID: 19290376
[TBL] [Abstract][Full Text] [Related]
13. Ferric complexes of 3-hydroxy-4-pyridinones characterized by density functional theory and Raman and UV-vis spectroscopies.
Šebestík J; Safařík M; Bouř P
Inorg Chem; 2012 Apr; 51(8):4473-81. PubMed ID: 22468647
[TBL] [Abstract][Full Text] [Related]
14. Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates.
Crisponi G; Nurchi VM; Pivetta T
J Inorg Biochem; 2008 Feb; 102(2):209-15. PubMed ID: 17854902
[TBL] [Abstract][Full Text] [Related]
15. Copper(II) complexes of tridentate pyridylmethylethylenediamines: role of ligand steric hindrance on DNA binding and cleavage.
Raja A; Rajendiran V; Uma Maheswari P; Balamurugan R; Kilner CA; Halcrow MA; Palaniandavar M
J Inorg Biochem; 2005 Aug; 99(8):1717-32. PubMed ID: 16039720
[TBL] [Abstract][Full Text] [Related]
16. L- and D-proline thiosemicarbazone conjugates: coordination behavior in solution and the effect of copper(II) coordination on their antiproliferative activity.
Milunovic MN; Enyedy É; Nagy NV; Kiss T; Trondl R; Jakupec MA; Keppler BK; Krachler R; Novitchi G; Arion VB
Inorg Chem; 2012 Sep; 51(17):9309-21. PubMed ID: 22889304
[TBL] [Abstract][Full Text] [Related]
17. Iron(III) chelating resins II. 3-Hydroxy-4(1H)-pyridinones-sepharose gels.
Feng M; van der Does L; Bantjes A
J Biomater Sci Polym Ed; 1992; 4(2):145-54. PubMed ID: 1486065
[TBL] [Abstract][Full Text] [Related]
18. New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.
Grazina R; Gano L; Sebestík J; Amelia Santos M
J Inorg Biochem; 2009 Feb; 103(2):262-73. PubMed ID: 19062099
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the aqueous iron(III) chelation chemistry of a potential Trojan Horse antimicrobial agent: chelate structure, stability and pH dependent speciation.
Harrington JM; Gootz T; Flanagan M; Lall M; O'Donnell J; Winton J; Mueller J; Crumbliss AL
Biometals; 2012 Oct; 25(5):1023-36. PubMed ID: 22855208
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
